Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-007686

Dake Benjamin T sold 10,284 shares at an average $21.80 ($224,160)

  • Dake Benjamin T acquired 10,284 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dake Benjamin T

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-08 Exercise or conversion : show line 1 in the form 10b5-1 +2,413 $1.74 $4,199 3,704 D
2023-05-08 Exercise or conversion : show line 2 in the form 10b5-1 +7,871 $2.14 $16,844 11,575 D
2023-05-08 Sale : show line 3 in the form 10b5-1 −8,685 $21.62 $187,805 2,890 D
2023-05-08 Sale : show line 4 in the form 10b5-1 −1,599 $22.74 $36,355 1,291 D
Open-market sales · 10,284 sh · avg $21.80 · $224,160

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-05-08 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −906 $1.74 2030-09-03 906 7,244 D
2023-05-08 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −1,507 $1.74 2030-09-03 1,507 22,602 D
2023-05-08 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) −1,018 $2.14 2031-04-01 1,018 23,423 D
2023-05-08 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) −6,853 $2.14 2031-04-01 6,853 171,314 D
Loading xslF345X04/form4-05092023_060505.xml…